Elsevier

Ophthalmology

Volume 105, Issue 2, February 1998, Pages 273-281
Ophthalmology

Photorefractive keratectomy: A 6-year follow-up study

https://doi.org/10.1016/S0161-6420(98)93055-XGet rights and content

Objective:

This study aimed to assess the long-term stability and efficacy of excimer laser photorefractive keratectomy.

Design:

Patients who participated in the first United Kingdom photorefractive keratectomy clinical trial were asked to attend a 6-year follow-up assessment.

Participants:

Eighty-three patients (68%) of the original cohort of 120 participants were observed for 6 years. A Summit Technology UV200 excimer laser with a 4-mm ablation zone had been used with patients allocated to one of six groups according to their preoperative refraction. Each group received one of the following spherical corrections: −2, −3, −4, −5, −6, or −7 diopters (D). Within each group, all patients received an identical treatment, and thus emmetropia was not the goal in all patients.

Intervention:

The induced refractive change, objective corneal haze, glare, and halo measurements, together with possible late-phase complications, were analyzed.

Main Outcome Measures:

All groups achieved a refractive undercorrection, and the magnitude of the undercorrection was related to the size of the attempted correction. The induced refraction stabilized by 6 to 12 months and has been maintained up to the 6-year follow-up stage.

Results:

Ninety-one percent of patients who underwent a −2.00-D correction and 76% of patients who received a −3.00-D correction were within ±1 D of the intended refraction at 6 years. Fifty-seven percent of the −4.00-D group and 50% of those in the −5.00-D group were within ±1 D, and this was reduced further to 43% in the −6.00-D group and 19% in the −7.00-D group. Six patients (7%) had evidence of residual corneal haze, which was visually significant in two patients (3%). Ten patients (12%) had significant night halos due to the small 4-mm ablation zone that was used in this early treatment trial.

Conclusions:

There was no further regression of the refraction after 1 year, and, more important, there was no sign of hyperopic shift or diurnal fluctuation in the patients' refraction. In addition, corneal haze appeared to reduce further with time, with no intraocular or retinal side effects being noted. Night halos remain a significant reported problem in a small number of patients who were treated with the 4-mm ablation zone.

References (38)

  • SalzJJ et al.

    A two-year experience with excimer laser photorefractive keratectomy for myopia

    Ophthalmology

    (1993)
  • LohmannCP et al.

    Corneal light scattering and visual performance in myopic individuals with spectacles, contact lenses, or excimer laser photorefractive keratectomy

    Am J Ophthalmol

    (1993)
  • WaringGO et al.

    Three-year results of the Prospective Evaluation of Radial Keratotomy (PERK) Study

    Ophthalmology

    (1987)
  • SantosVR et al.

    Morning-to-evening change in refraction, corneal curvature, and visual acuity 2 to 4 years after radial keratotomy in the PERK Study

    Ophthalmology

    (1988)
  • McDonnellPJ et al.

    Morning-to-evening change in refraction, corneal curvature, and visual acuity 11 years after radial keratotomy in the Prospective Evaluation of Radial Keratotomy Study

    Ophthalmology

    (1996)
  • KruegerRR et al.

    Interaction of ultraviolet laser light with the cornea

    Invest Ophthalmol Vis Sci

    (1985)
  • MarshallJ et al.

    Photoablative reprofiling of the cornea using an excimer laser: photorefractive keratectomy

    Lasers Ophthalmol

    (1986)
  • MarshallJ et al.

    A comparative study of corneal incisions induced by diamond and steel knives and two ultraviolet radiations from an excimer laser

    Br J Ophthalmol

    (1986)
  • TuftSJ et al.

    Corneal repair following keratectomy

    A comparison between conventional surgery and laser photoablation

    Invest Ophthalmol Vis Sci

    (1989)
  • Cited by (70)

    • Outcome of posterior chamber phakic intraocular lens procedure to correct myopia

      2013, Saudi Journal of Ophthalmology
      Citation Excerpt :

      Various techniques, some complementary and some overlapping, can predictably, safely and permanently treat low, moderate and high myopia.1–7 Corneal surgery shows the greatest promise but is controversial for higher corrections because of increased tissue removal, small ablation zones, increased aberrations, and poor predictability.9–14 Clear lens extraction for high and extreme myopia exposes the patient to the risk of retinal detachment and cystoid macular edema (CME).15

    • Ten-Year Follow-up of Photorefractive Keratectomy for Myopia of More Than -6 Diopters

      2008, American Journal of Ophthalmology
      Citation Excerpt :

      Other studies of PRK for moderate myopia with less than two years of follow-up found that between 40.5% and 90% of eyes were within ± 1.00 D after surgery.14,18–22 Long-term follow-up studies of PRK for low to moderate myopia demonstrated that refractive stability was achieved by one year and was maintained at up to 12 years with no significant hyperopic shift, late regression, or fluctuation.11–14 Other studies suggested that myopic ablations were accompanied by a hyperopic shift and that the magnitude of the hyperopic shift increased with the magnitude of attempted correction.23,24

    • Effects of Ablation Diameter on Long-term Refractive Stability and Corneal Transparency after Photorefractive Keratectomy

      2006, Ophthalmology
      Citation Excerpt :

      This study shows that there was no significant change in postoperative refractive outcome between 1 and 10 to 12 years after PRK with different optical zone corrections (Table 3; Figs 1, 2). The long-term refractive stability after 4.0-mm PRK has been reported previously.8,9 Similarly, the refractive stability was maintained in the 5.0- and 6.0-mm ablation groups in the long term, confirming the safety of larger-zone PRK.

    View all citing articles on Scopus

    Presented at ARVO, Fort Lauderdale, Florida, May 1997.

    Supported by the Iris Fund for the Prevention of Blindness, London, England (CGS).

    1

    John Marshall is a consultant for Summit Technology.

    View full text